| Code | Description | Claims | Beneficiaries | Total Paid |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
14,551 |
13,623 |
$2.20M |
| G0378 |
Hospital observation service, per hour |
1,698 |
1,546 |
$1.50M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
9,740 |
9,393 |
$1.48M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,969 |
8,649 |
$1.22M |
| A0431 |
Ambulance service, conventional air services, transport, one way (rotary wing) |
126 |
120 |
$374K |
| T1015 |
Clinic visit/encounter, all-inclusive |
7,149 |
3,409 |
$324K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,855 |
3,676 |
$308K |
| 87536 |
|
1,257 |
1,236 |
$168K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,571 |
1,513 |
$157K |
| 0002A |
|
3,091 |
3,065 |
$131K |
| 0001A |
|
3,274 |
3,257 |
$117K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
2,836 |
2,745 |
$115K |
| 80053 |
Comprehensive metabolic panel |
14,517 |
12,863 |
$111K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
4,011 |
3,841 |
$106K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,843 |
3,680 |
$97K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
26,535 |
23,115 |
$93K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
7,190 |
6,754 |
$90K |
| A0436 |
Rotary wing air mileage, per statute mile |
130 |
125 |
$86K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,838 |
1,742 |
$65K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
3,990 |
1,341 |
$64K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
243 |
234 |
$54K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,019 |
1,939 |
$49K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
719 |
691 |
$47K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
392 |
377 |
$46K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,465 |
2,336 |
$45K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
8,958 |
7,816 |
$45K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
471 |
453 |
$45K |
| 80050 |
General health panel |
827 |
798 |
$44K |
| 80061 |
Lipid panel |
2,770 |
2,681 |
$43K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,691 |
1,649 |
$42K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
8,619 |
7,940 |
$41K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
419 |
408 |
$41K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,096 |
1,010 |
$40K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
985 |
977 |
$39K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
706 |
679 |
$39K |
| 97161 |
|
966 |
900 |
$34K |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
684 |
677 |
$32K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
869 |
850 |
$32K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
556 |
543 |
$32K |
| A0426 |
Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) |
116 |
114 |
$31K |
| 88184 |
|
743 |
733 |
$31K |
| 0225U |
|
186 |
181 |
$30K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
622 |
604 |
$30K |
| 88185 |
|
950 |
704 |
$28K |
| 70496 |
|
312 |
295 |
$27K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
661 |
634 |
$27K |
| 87481 |
|
526 |
514 |
$26K |
| 86803 |
|
1,501 |
1,465 |
$25K |
| 29581 |
|
1,667 |
447 |
$25K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,678 |
2,408 |
$23K |
| 0031A |
|
644 |
641 |
$23K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
199 |
186 |
$22K |
| 70498 |
|
289 |
278 |
$21K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
140 |
132 |
$21K |
| 84484 |
|
3,500 |
3,013 |
$18K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,388 |
1,290 |
$18K |
| 84702 |
|
2,235 |
2,060 |
$17K |
| 71250 |
|
302 |
294 |
$16K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,211 |
2,146 |
$16K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
55 |
55 |
$16K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
903 |
324 |
$16K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
587 |
568 |
$16K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
101 |
100 |
$15K |
| 71045 |
Radiologic examination, chest; single view |
4,080 |
3,794 |
$15K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
214 |
211 |
$14K |
| 86780 |
|
766 |
719 |
$13K |
| 83735 |
|
2,647 |
1,869 |
$13K |
| 93971 |
|
262 |
252 |
$13K |
| 71046 |
Radiologic examination, chest; 2 views |
1,408 |
1,347 |
$13K |
| 87522 |
Neg quan hep c or qual rna |
296 |
279 |
$12K |
| 76642 |
|
261 |
218 |
$12K |
| 97165 |
|
539 |
494 |
$12K |
| 86834 |
|
42 |
36 |
$12K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
267 |
256 |
$11K |
| 83880 |
|
622 |
583 |
$11K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
682 |
641 |
$11K |
| 86835 |
|
42 |
36 |
$10K |
| 84466 |
|
632 |
596 |
$10K |
| 84439 |
|
1,034 |
987 |
$9K |
| 36415 |
Collection of venous blood by venipuncture |
10,133 |
8,715 |
$9K |
| 85610 |
|
3,469 |
2,837 |
$9K |
| 72141 |
|
40 |
39 |
$9K |
| 87340 |
|
527 |
513 |
$9K |
| 85027 |
|
1,440 |
1,284 |
$9K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
60 |
55 |
$9K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,189 |
1,072 |
$9K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
335 |
327 |
$9K |
| 82607 |
|
807 |
780 |
$9K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
304 |
299 |
$9K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,243 |
1,163 |
$8K |
| 95886 |
|
148 |
145 |
$8K |
| 80076 |
|
1,185 |
1,107 |
$8K |
| 93970 |
|
129 |
120 |
$8K |
| 87205 |
|
1,518 |
1,456 |
$7K |
| 70486 |
|
177 |
174 |
$7K |
| 84153 |
|
280 |
266 |
$7K |
| 84403 |
|
207 |
198 |
$7K |
| 82728 |
|
627 |
590 |
$7K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
46 |
43 |
$6K |
| 86850 |
|
1,105 |
1,059 |
$6K |
| 97162 |
|
261 |
248 |
$6K |
| 83970 |
|
136 |
128 |
$6K |
| 0100U |
|
161 |
153 |
$6K |
| 84100 |
|
1,314 |
882 |
$5K |
| 82570 |
|
671 |
646 |
$5K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
57 |
55 |
$5K |
| 86360 |
|
77 |
77 |
$5K |
| 83540 |
|
650 |
617 |
$5K |
| 87040 |
|
403 |
384 |
$5K |
| 82043 |
|
499 |
488 |
$5K |
| 85730 |
|
1,511 |
1,382 |
$5K |
| 83690 |
|
1,957 |
1,791 |
$5K |
| G0328 |
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous |
212 |
209 |
$5K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
64 |
62 |
$4K |
| 96376 |
|
752 |
609 |
$4K |
| 82784 |
|
173 |
161 |
$4K |
| 77336 |
|
97 |
54 |
$4K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
328 |
311 |
$4K |
| 81001 |
|
2,491 |
2,369 |
$4K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
42 |
42 |
$4K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
36 |
34 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,314 |
979 |
$4K |
| 80299 |
|
236 |
228 |
$4K |
| 82805 |
|
252 |
232 |
$4K |
| 86359 |
|
77 |
77 |
$4K |
| 73610 |
|
336 |
311 |
$4K |
| 83615 |
|
659 |
457 |
$4K |
| 82550 |
|
777 |
647 |
$4K |
| 87070 |
|
639 |
604 |
$4K |
| 88342 |
|
110 |
103 |
$4K |
| 74174 |
|
15 |
14 |
$3K |
| 86357 |
|
77 |
77 |
$3K |
| 73030 |
|
350 |
325 |
$3K |
| 86355 |
|
77 |
77 |
$3K |
| 73560 |
|
441 |
410 |
$3K |
| 90715 |
|
1,050 |
962 |
$3K |
| 87186 |
|
506 |
482 |
$3K |
| 86706 |
|
221 |
212 |
$3K |
| 93975 |
|
41 |
40 |
$3K |
| 86900 |
|
1,110 |
1,062 |
$3K |
| 86901 |
|
1,105 |
1,058 |
$3K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
317 |
271 |
$3K |
| 84999 |
|
788 |
728 |
$3K |
| 73130 |
|
373 |
330 |
$3K |
| 73630 |
|
440 |
384 |
$3K |
| 86038 |
|
153 |
148 |
$3K |
| 83605 |
|
834 |
728 |
$3K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
24 |
23 |
$3K |
| 86762 |
|
102 |
102 |
$3K |
| 87081 |
|
560 |
544 |
$3K |
| 85379 |
|
559 |
533 |
$3K |
| 84550 |
|
444 |
298 |
$3K |
| 81003 |
|
1,177 |
1,128 |
$2K |
| 83001 |
|
99 |
98 |
$2K |
| 87075 |
|
309 |
287 |
$2K |
| 80197 |
|
223 |
143 |
$2K |
| 0003A |
|
109 |
106 |
$2K |
| 77066 |
Tomosynthesis, mammo |
33 |
33 |
$2K |
| 86140 |
|
876 |
810 |
$2K |
| 72100 |
|
137 |
132 |
$2K |
| 77334 |
|
23 |
14 |
$2K |
| 86480 |
|
26 |
26 |
$2K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
61 |
59 |
$2K |
| 86255 |
|
79 |
74 |
$2K |
| 76536 |
|
39 |
38 |
$2K |
| 76830 |
Ultrasound, transvaginal |
42 |
41 |
$2K |
| 84402 |
|
61 |
59 |
$2K |
| 93922 |
|
76 |
71 |
$2K |
| 86592 |
|
401 |
390 |
$2K |
| 70491 |
|
43 |
42 |
$2K |
| 86704 |
|
102 |
97 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
7,055 |
4,422 |
$2K |
| 85652 |
|
782 |
729 |
$2K |
| 93017 |
|
118 |
117 |
$2K |
| 87077 |
|
325 |
312 |
$2K |
| J3490 |
Unclassified drugs |
4,602 |
3,360 |
$2K |
| 73502 |
|
174 |
157 |
$2K |
| 72040 |
|
127 |
125 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
9,127 |
6,569 |
$2K |
| 82565 |
|
295 |
283 |
$2K |
| 62323 |
|
13 |
13 |
$2K |
| 82746 |
|
183 |
172 |
$2K |
| 76942 |
|
138 |
126 |
$1K |
| 73590 |
|
184 |
169 |
$1K |
| 72131 |
|
42 |
41 |
$1K |
| 73110 |
|
201 |
185 |
$1K |
| 82962 |
|
1,720 |
1,190 |
$1K |
| 86618 |
|
56 |
54 |
$1K |
| 80320 |
|
208 |
198 |
$1K |
| 88341 |
|
16 |
13 |
$1K |
| 74018 |
|
173 |
162 |
$1K |
| 84146 |
|
41 |
40 |
$1K |
| 80348 |
|
23 |
21 |
$1K |
| 81025 |
|
744 |
715 |
$1K |
| A9270 |
Non-covered item or service |
34,581 |
10,164 |
$1K |
| C1769 |
Guide wire |
252 |
224 |
$992.87 |
| 97164 |
|
27 |
26 |
$971.68 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,747 |
1,654 |
$961.56 |
| 97597 |
|
28 |
13 |
$955.73 |
| 84145 |
|
150 |
131 |
$934.35 |
| 82553 |
|
228 |
212 |
$890.65 |
| 76775 |
|
26 |
25 |
$841.85 |
| 83516 |
|
71 |
70 |
$816.19 |
| 72128 |
|
24 |
24 |
$791.71 |
| 87147 |
|
271 |
252 |
$786.93 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
6,363 |
5,005 |
$753.30 |
| 88312 |
|
15 |
14 |
$723.85 |
| 87486 |
|
46 |
43 |
$683.23 |
| 88142 |
|
30 |
30 |
$680.28 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
306 |
292 |
$636.15 |
| J2785 |
Injection, regadenoson, 0.1 mg |
17 |
12 |
$632.26 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
12 |
12 |
$627.21 |
| 82533 |
|
40 |
36 |
$617.82 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
83 |
26 |
$607.79 |
| 76937 |
|
129 |
119 |
$558.52 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
7,422 |
5,180 |
$556.99 |
| 82248 |
|
98 |
93 |
$556.20 |
| 77300 |
|
15 |
12 |
$542.89 |
| 84156 |
|
110 |
101 |
$537.62 |
| A0425 |
Ground mileage, per statute mile |
378 |
364 |
$535.33 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
3,104 |
2,014 |
$505.96 |
| 87631 |
|
13 |
13 |
$500.09 |
| 86708 |
|
26 |
26 |
$493.36 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
261 |
145 |
$488.56 |
| 99152 |
|
164 |
156 |
$431.11 |
| 73090 |
|
65 |
60 |
$419.58 |
| 84480 |
|
53 |
52 |
$411.02 |
| 99153 |
Mod sedat endo service >5yrs |
148 |
133 |
$400.51 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
204 |
189 |
$384.78 |
| 77062 |
|
13 |
13 |
$378.59 |
| 0296T |
|
14 |
14 |
$352.28 |
| 84481 |
|
12 |
12 |
$348.59 |
| J1644 |
Injection, heparin sodium, per 1000 units |
4,408 |
1,875 |
$336.29 |
| 82950 |
|
41 |
38 |
$326.95 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
27 |
27 |
$320.61 |
| 86160 |
|
14 |
14 |
$307.06 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
605 |
334 |
$302.87 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
140 |
134 |
$300.65 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
621 |
438 |
$288.47 |
| 84134 |
|
28 |
26 |
$282.17 |
| 83002 |
|
12 |
12 |
$266.93 |
| 86787 |
|
14 |
13 |
$266.31 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,823 |
4,626 |
$261.35 |
| 88304 |
|
70 |
64 |
$260.09 |
| 97166 |
|
28 |
25 |
$258.01 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,371 |
1,013 |
$255.75 |
| 93246 |
|
13 |
13 |
$255.47 |
| 87088 |
|
45 |
40 |
$235.70 |
| 84165 |
|
13 |
12 |
$221.74 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,596 |
2,848 |
$213.30 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,704 |
790 |
$199.10 |
| 86593 |
|
24 |
24 |
$193.86 |
| 82947 |
|
39 |
37 |
$184.05 |
| J1815 |
Injection, insulin, per 5 units |
1,614 |
589 |
$182.14 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
7,723 |
5,731 |
$176.14 |
| 73562 |
|
25 |
25 |
$173.44 |
| 85045 |
|
40 |
29 |
$162.61 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
25 |
25 |
$150.42 |
| 83525 |
|
13 |
13 |
$147.62 |
| 80349 |
|
13 |
13 |
$142.60 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
159 |
98 |
$141.35 |
| 0064A |
|
43 |
43 |
$137.50 |
| 87581 |
|
46 |
43 |
$132.24 |
| 84425 |
|
12 |
12 |
$120.24 |
| 86431 |
|
12 |
12 |
$112.68 |
| 80329 |
|
20 |
20 |
$112.44 |
| 84436 |
|
14 |
14 |
$107.89 |
| 88307 |
|
29 |
26 |
$107.22 |
| 82977 |
|
14 |
12 |
$107.02 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
853 |
621 |
$103.28 |
| 82150 |
|
16 |
13 |
$94.45 |
| 73070 |
|
13 |
13 |
$92.52 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
456 |
269 |
$88.95 |
| J7999 |
Compounded drug, not otherwise classified |
795 |
690 |
$87.93 |
| 85396 |
|
12 |
12 |
$83.55 |
| 82010 |
|
46 |
41 |
$82.73 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,655 |
1,220 |
$75.63 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
606 |
454 |
$69.61 |
| 97116 |
|
25 |
12 |
$68.60 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
42 |
40 |
$67.20 |
| J2060 |
Injection, lorazepam, 2 mg |
404 |
254 |
$62.08 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
4,416 |
3,673 |
$53.89 |
| 89051 |
|
19 |
14 |
$47.96 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
314 |
273 |
$39.19 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
24 |
24 |
$38.39 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
3,627 |
3,013 |
$36.70 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
302 |
223 |
$34.23 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
560 |
436 |
$33.09 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
90 |
67 |
$31.59 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
540 |
425 |
$28.16 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
50 |
39 |
$26.40 |
| 82077 |
|
28 |
24 |
$24.64 |
| C9113 |
Injection, pantoprazole sodium, per vial |
152 |
82 |
$17.04 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
39 |
25 |
$5.45 |
| J7050 |
Infusion, normal saline solution, 250 cc |
206 |
156 |
$4.68 |
| 81002 |
|
18 |
17 |
$3.87 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
58 |
49 |
$1.68 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
2,996 |
2,370 |
$0.11 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
200 |
137 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
12 |
12 |
$0.00 |
| 0051A |
|
21 |
21 |
$0.00 |
| 0052A |
|
13 |
13 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
309 |
267 |
$0.00 |
| 0071A |
|
34 |
34 |
$0.00 |
| 0004A |
|
27 |
27 |
$0.00 |
| 0054A |
|
31 |
31 |
$0.00 |